Literature DB >> 26444081

Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.

Li B Li1, Chao Ma2,3, Geneve Awong4,5,6,7, Marion Kennedy4,5,6, German Gornalusse1, Gordon Keller4,5,6, Dan S Kaufman3,8, David W Russell1,9.   

Abstract

Many applications of pluripotent stem cells (PSCs) require efficient editing of silent chromosomal genes. Here, we show that a major limitation in isolating edited clones is silencing of the selectable marker cassette after homologous recombination and that this can be overcome by using a ubiquitous chromatin opening element (UCOE) promoter-driven transgene. We use this strategy to edit the silent IL2RG locus in human PSCs with a recombinant adeno-associated virus (rAAV)-targeting vector in the absence of potentially genotoxic, site-specific nucleases and show that IL2RG is required for natural killer and T-cell differentiation of human PSCs. Insertion of an active UCOE promoter into a silent locus altered the histone modification and cytosine methylation pattern of surrounding chromatin, but these changes resolved when the UCOE promoter was removed. This same approach could be used to correct IL2RG mutations in X-linked severe combined immunodeficiency patient-derived induced PSCs (iPSCs), to prevent graft versus host disease in regenerative medicine applications, or to edit other silent genes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26444081      PMCID: PMC4786911          DOI: 10.1038/mt.2015.190

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  61 in total

1.  Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element.

Authors:  M A Ripoche; C Kress; F Poirier; L Dandolo
Journal:  Genes Dev       Date:  1997-06-15       Impact factor: 11.361

2.  Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE).

Authors:  Marianne Lindahl Allen; Michael Antoniou
Journal:  Epigenetics       Date:  2007-10-31       Impact factor: 4.528

3.  Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.

Authors:  Kevin A D'Amour; Anne G Bang; Susan Eliazer; Olivia G Kelly; Alan D Agulnick; Nora G Smart; Mark A Moorman; Evert Kroon; Melissa K Carpenter; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2006-10-19       Impact factor: 54.908

4.  Gene targeting in stem cells from individuals with osteogenesis imperfecta.

Authors:  Joel R Chamberlain; Ulrike Schwarze; Pei-Rong Wang; Roli K Hirata; Kurt D Hankenson; James M Pace; Robert A Underwood; Kit M Song; Michael Sussman; Peter H Byers; David W Russell
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

5.  Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.

Authors:  Valarie McCullar; Robert Oostendorp; Angela Panoskaltsis-Mortari; Gong Yun; Charles T Lutz; John E Wagner; Jeffrey S Miller
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Generation of insulin-producing islet-like clusters from human embryonic stem cells.

Authors:  Jianjie Jiang; Melinda Au; Kuanghui Lu; Alana Eshpeter; Gregory Korbutt; Greg Fisk; Anish S Majumdar
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

9.  Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets.

Authors:  Xingshen Sun; Ziying Yan; Yaling Yi; Ziyi Li; Diana Lei; Christopher S Rogers; Juan Chen; Yulong Zhang; Michael J Welsh; Gregory H Leno; John F Engelhardt
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer.

Authors:  Christopher S Rogers; Yanhong Hao; Tatiana Rokhlina; Melissa Samuel; David A Stoltz; Yuhong Li; Elena Petroff; Daniel W Vermeer; Amanda C Kabel; Ziying Yan; Lee Spate; David Wax; Clifton N Murphy; August Rieke; Kristin Whitworth; Michael L Linville; Scott W Korte; John F Engelhardt; Michael J Welsh; Randall S Prather
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more
  4 in total

Review 1.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

2.  Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.

Authors:  Takafumi Hiramoto; Li B Li; Sarah E Funk; Roli K Hirata; David W Russell
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

3.  Evaluating the Genomic Parameters Governing rAAV-Mediated Homologous Recombination.

Authors:  Laura P Spector; Matthew Tiffany; Nicole M Ferraro; Nathan S Abell; Stephen B Montgomery; Mark A Kay
Journal:  Mol Ther       Date:  2020-11-26       Impact factor: 11.454

Review 4.  Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.

Authors:  Ponthip Pratumkaew; Surapol Issaragrisil; Sudjit Luanpitpong
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.